Place of care and costs associated with acute episodes and remission in bipolar I disorder

被引:3
|
作者
McIntyre, Roger S. [1 ]
Higa, Sara [2 ]
Doan, Quan, V [3 ]
Amari, Diana [3 ]
Oliveri, David [3 ]
Gillard, Patrick [2 ]
Harrington, Amanda [2 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] AbbVie, Irvine, CA USA
[3] Genesis Res, Hoboken, NJ USA
关键词
Bipolar I disorder; mania; depression; remission; inpatient costs; outpatient costs; claims database analysis; ECONOMIC BURDEN; UNITED-STATES; ADHERENCE; OUTCOMES;
D O I
10.1080/13696998.2022.2120264
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims To our knowledge, literature describing the place of care and associated costs during acute bipolar I disorder (BP-I) episodes is limited. We conducted a claims-based retrospective study to address this gap. Materials and methods Adults with BP-I were identified via IBM MarketScan Commercial and Medicare Supplemental databases. The acute episode index date was defined by >= 1 inpatient BP-I claim(s) or >= 1 outpatient or >= 3 outpatient BP-I claims (depending on visit type) in a 2-week (manic/mixed) or 4-week (depressive) period. Likely acute episodes were defined as 3- and 6-week periods for manic/mixed and depressive episodes, respectively; total mental health-related medical costs (health plan + patient) were collected during these intervals and stratified by setting (inpatient versus outpatient). Initial and subsequent episodes were captured; data were reported in subgroups without and with clozapine use, a proxy for disease severity. The remission index date was the earliest outpatient claim with a bipolar remission diagnosis with no acute episode or treatment. Remission costs were collected over a 3-month period. All results were analyzed descriptively. Results A total of 41,516 patients with 130,221 acute manic/mixed episodes and 47,763 patients with 149,207 acute depressive episodes met the study criteria. Over 84% of acute episodes were treated in outpatient settings. Mental health-related medical costs for manic/mixed episodes were $15,444 for inpatient and $1,577 for outpatient settings; inpatient and outpatient costs for depressive episodes were $17,376 and $2,154, respectively. Health plans covered approximately 78% of medical costs for both episode types with and without prior clozapine use. A total of 8,143 patients met remission criteria; the total 3-month outpatient costs were $1,225. Conclusions Most BP-I acute manic/mixed or depressive episodes were treated in the outpatient setting. Episodes with inpatient care were 8-10 times more costly than outpatient-only episodes. Health plans covered most medical costs, but additional patient-incurred out-of-pocket costs remained.
引用
收藏
页码:1110 / 1117
页数:8
相关论文
共 50 条
  • [21] AripiprazoleIn Acute Mania Associated with Bipolar I Disorder
    Katherine A. Lyseng-Williamson
    Caroline M. Perry
    CNS Drugs, 2004, 18 : 367 - 376
  • [22] Aripiprazole - In acute mania associated with bipolar I disorder
    Lyseng-Williamson, KA
    Perry, CM
    CNS DRUGS, 2004, 18 (06) : 367 - 376
  • [23] Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder
    Soeiro-de-Souza, Marcio Gerhardt
    Andreazza, Ana C.
    Carvalho, Andre F.
    Machado-Vieira, Rodrigo
    Young, L. Trevor
    Moreno, Ricardo Alberto
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (07): : 1505 - 1512
  • [24] Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France
    de Zelicourt, M
    Dardennes, R
    Verdoux, H
    Gandhi, G
    Edgell, ET
    Fagnani, F
    EUROPEAN PSYCHIATRY, 2002, 17 : 108S - 108S
  • [25] Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: A pilot study
    Huang, Ming-Chyi
    Chuang, Shan-Chi
    Tseng, Mei-Chih Meg
    Chien, Yi-Ling
    Liao, Shih-Cheng
    Chen, Hsi-Chung
    Kuo, Po-Hsiu
    PSYCHIATRY RESEARCH, 2017, 258 : 594 - 597
  • [26] Costs associated with the treatment of patients with bipolar disorder in a managed care organization
    Knoth, RL
    Chen, K
    Tafesse, E
    PSYCHIATRIC SERVICES, 2004, 55 (12) : 1353 - 1353
  • [27] Topiramate for the treatment of children and adolescents with acute manic or mixed episodes of bipolar I disorder
    DelBello, MP
    Findling, RL
    Kushner, S
    Wang, D
    Olson, WH
    Capece, JA
    Fazzio, L
    Rosenthal, N
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S155 - S155
  • [28] Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder
    Canas, Fernando
    Correll, Christoph U.
    Fagiolini, Andrea
    Larmo, Ilkka
    Levy, Pedro
    Papageorgiou, Georgios
    Rossi, Alessandro
    Zink, Marhias
    Manuel Montes, Jose
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (14) : 2245 - 2263
  • [29] Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder
    Suppes, Trisha
    Eudicone, James
    McQuade, Robert
    Pikalov, Andrei, III
    Carlson, Berit
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 (1-3) : 145 - 154
  • [30] Cognitive styles in hypomanic episodes of bipolar I disorder
    Lex, Claudia
    Hautzinger, Martin
    Meyer, Thomas D.
    BIPOLAR DISORDERS, 2011, 13 (04) : 355 - 364